Elisabet Lidbrink - Concepedia

Author

Elisabet Lidbrink

Karolinska University Hospital ORCID

Also Known As

E Lidbrink, E. Lidbrink, Elisabet K. Lidbrink, Elisabet Kerstin Lidbrink, Elisabet Lidbrink, T Schröder

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Karolinska University Hospital Karolinska Institutet Sophiahemmet Hospital Stockholm South General Hospital Uppsala University Hospital

About

Elisabet Lidbrink is an author at Karolinska University Hospital specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	2K
2	Health Sciences	5	5	122
3	Public Health	3	3	343
4	Nursing	2	2	101
5	Engineering	1	1	16

Elisabet Lidbrink

Publications

3.4K

Citations

H-Index

Page 1

	Year	Citations
Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression Linda S. Lindström, Eva Karlsson, Ulla Wilking, Journal of Clinical Oncology Hormonal ReceptorsBreast OncologyProgesterone ReceptorEndocrine-related CancerMedicine	2012	517
Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial Jonas Bergh, Tom Wiklund, Björn Erikstein, The Lancet Breast OncologyOncologyHigh-risk Breast CancerRandomised TrialPharmacology	2000	342
FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer Jonas Bergh, Per‐Ebbe Jönsson, Elisabet Lidbrink, Journal of Clinical Oncology	2012	264
Randomized study of mammography screening — preliminary report on mortality in the stockholm trial Jan Frisell, Gunnar Eklund, Lennart Hellström, Breast Cancer Research and Treatment Stockholm TrialCancer DetectionCancer ScreeningEpidemiology Of CancerBreast Imaging	1991	262
Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial Jan Frisell, Elisabet Lidbrink, Lars Hellström, Breast Cancer Research and Treatment Cancer DetectionCancer ScreeningMedicineYears – UpdateEpidemiology Of Cancer	1997	223
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial Hervé Bonnefoi, Martine Piccart, Jan Bogaerts, The Lancet Oncology Tp53 StatusBreast OncologyMedicineRandomised Phase 3Pathology	2011	125
Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial Håkan Norell, Isabel Poschke, Jehad Charo, Journal of Translational Medicine	2010	122
Neglected aspects of false positive findings of mammography in breast cancer screening: analysis of false positive cases from the Stockholm trial Elisabet Lidbrink, J Elfving, Jan Frisell, BMJ	1996	120
HER2 status in a population-derived breast cancer cohort: discordances during tumor progression Ulla Wilking, Eva Karlsson, Lambert Skoog, Breast Cancer Research and Treatment Her2 StatusBreast OncologyCancer EpidemiologyMedicineTumor Progression	2010	118
Treatment Failure and Dietary Habits in Women With Breast Cancer Lars Erik Holm, E. Nordevang, Marie-Louise Hjalmar, JNCI Journal of the National Cancer Institute	1993	118

Page 1